Plus Therapeutics Inc. (PSTV)
NASDAQ: PSTV
· Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM
0.57
-9.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
Plus Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.4M | -3.9M | -2.87M | -2.94M | -3.26M | -3.81M | -3.22M | -1.48M | -4.8M | -5.66M | -5.22M | -5.28M | -4.12M | -4.16M | -3.72M | -2.8M | -2.72M |
Depreciation & Amortization | 146K | 103K | 232K | 202K | 186K | 65K | 245K | 188K | 187K | 159K | 224K | 130K | 147K | 129K | 87K | 94K | 88K |
Stock-Based Compensation | 148K | 128K | 125K | 151K | 146K | 141K | 148K | 140K | 140K | 130K | 129K | 167K | 180K | 181K | 180K | 138K | 107K |
Other Working Capital | n/a | 2.37M | -1.12M | 2.2M | -1.56M | 1.19M | 368K | -1.68M | -1.38M | -1.57M | 518K | 27K | 459K | -926K | 23K | 159K | -170K |
Other Non-Cash Items | 12.49M | 88K | -1.01M | -1.17M | 17K | 268K | 59K | 53K | 68K | 208K | 53K | 141K | 104K | 413K | 182K | 132K | 150K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -121K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.44M | 2.37M | -156K | 2.61M | -1.6M | 1.58M | 368K | -1.68M | -1.38M | 2.93M | 591K | 2.2M | -191K | 808K | 1.02M | 37K | -631K |
Operating Cash Flow | -6.17M | -1.21M | -3.68M | -1.15M | -4.51M | -1.88M | -2.4M | -2.78M | -5.79M | -2.23M | -4.22M | -2.64M | -3.88M | -2.62M | -2.25M | -2.4M | -3.01M |
Capital Expenditures | -3K | -11K | -14K | -626K | -40K | -42K | -10K | -11K | -97K | -11K | -33K | -138K | -577K | -10K | -54K | 4K | -84K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -8.45M | -3.65M | -3.18M | -324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 3.53M | 8.52M | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 30K | n/a | n/a | -545K | n/a | n/a | n/a | n/a | n/a | 117K | n/a | n/a | -367K | 12K | 50K | n/a | n/a |
Investing Cash Flow | 3.56M | 64K | -9K | -3.8M | -364K | -42K | -10K | -11K | -97K | -11K | -33K | -138K | -577K | 2K | -4K | 4K | -84K |
Debt Repayment | -7M | 4M | n/a | -302K | -402K | -402K | -402K | -402K | -402K | -402K | -402K | -402K | -402K | -268K | n/a | -2K | -6K |
Common Stock Repurchased | n/a | n/a | 374K | n/a | -374K | -126K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 917K | n/a | -7.64M | 10.56M | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.02M |
Financial Cash Flow | 12.4M | n/a | n/a | 6.96M | -776K | -529K | 2.52M | 961K | 493K | 99K | 6.43M | -371K | 7.29M | -258K | 6.37M | 5.11M | 9.19M |
Net Cash Flow | 9.79M | -1.15M | -3.69M | 2.01M | -5.65M | -2.45M | 111K | -1.83M | -5.4M | -2.15M | 2.18M | -3.15M | 2.84M | -2.88M | 4.12M | 2.71M | 6.1M |
Free Cash Flow | -6.17M | -1.22M | -3.69M | -1.78M | -4.55M | -1.92M | -2.41M | -2.79M | -5.89M | -2.25M | -4.25M | -2.78M | -4.45M | -2.63M | -2.31M | -2.4M | -3.09M |